HemoMax 100 mg/5 ml (IV Injection or Infusion)
5 ml ampoule: ৳ 325.00
Medicine Details
Category | Details |
---|---|
Generic | Iron sucrose |
Company | Pharmasia limited |
Number of Color Options
- 1
Dimensions
- 5-10 ml
Injection Method
- Intravenous
Mode of Action
- Haematinic
- Polynuclear Iron (III) Hydroxide in Sucrose
Applicable Population
- Adults
- Elderly
- Children
Administered Frequency
- Once to three times a week
Pharmacological Characteristics
- Sterile
- Aqueous
PH Range
- 10.5-11.1
Administration Options
- Injection
- Infusion
Maximum Injected Amount
- 10 ml (200 mg Iron)
Dilution Recommendations
- Max. 20 ml 0.9% w/v Sodium Chloride
- Max. 100 ml 0.9% w/v Sodium Chloride
- Max. 500 ml 0.9% w/v Sodium Chloride
Infusion Time
- at least 15 minutes
- at least 30 minutes
- at least 1.5 hours
- at least 3.5 hours
Clash with Oral Medications
- Oral iron preparations
Indications
- Rapid HemoMax supply
- Patients intolerant to oral HemoMax therapy
- Active inflammatory bowel disease
- Non-dialysis dependent-chronic kidney disease patients
- Hemodialysis dependent-chronic kidney disease patients
- Peritoneal dialysis dependent-chronic kidney disease patients
- Patients undergoing surgical procedures
- Patients donating blood
- Postpartum patients
Contraindications
- Evidence of Iron overload
- Hypersensitivity to Iron Sucrose
- Anaemia not caused by Iron deficiency
- History of allergic disorders
- Liver disease
- Infections
Side Effects
- Hypotension
- Leg cramps
- Nausea
- Headache
- Vomiting
- Diarrhea
- Fever
- Chest pain
- Hypertension
- Dyspnea
- Pneumonia
- Pruritus
Pregnancy Category
- B
Precautions
- HemoMax excretion monitoring
- Hypersensitivity reaction caution
- Hypotension caution
Pediatric Use
- Safety and effectiveness not established
Geriatric Use
- No overall differences in safety observed
Administered into Dialyser
- Direct intravenous injection
Dosage in Special Population
- Hemodialysis Dependent-Chronic Kidney Disease Patients: 100 mg slow intravenous injection or infusion of 100 mg
- Non-Dialysis Dependent-Chronic Kidney Disease Patient: Total cumulative dose 1000 mg over a 14 day period
Overdose Effects
- Accumulation in storage sites
- Symptoms include hypotension, headache, vomiting
Storage Conditions
- Cool and dry place
- Protected from light
- Do not freeze
Related Brands
- Anefer 100 mg/5 ml (IV Injection or Infusion) - opsonin-pharma-ltd
- Anofer 100 mg/5 ml (IV Injection or Infusion) - monicopharma-ltd
- Defiron 100 mg/5 ml (IV Injection or Infusion) - square-pharmaceuticals-plc
- Ferimax 100 mg/5 ml (IV Injection or Infusion) - incepta-pharmaceuticals-ltd
- Feristar 100 mg/5 ml (IV Injection or Infusion) - renata-limited